LACERTA THERAPEUTICS, INC.
ALACHUA, FL · Founded 2017 · CIK 0001748465 · Biotech · Defunct
AAV-based genetic therapy vectors targeting glioblastoma stem cell master regulators
- Grants
- $2.5M
- 4 awards
- Sector median: 1
- Raised
- $500K
- 2 Form D · Aug 2018
- 98 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Targeting glioblastoma stem-like cells with custom-designed viral vectors | $300,000 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $30,000,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Targeting glioblastoma stem-like cells with custom-designed viral vectors | $999,999 | |
| Federal grant | Department of Health and Human Services · Phase II · Targeting glioblastoma stem-like cells with custom-designed viral vectors | $156,335 | |
| Federal grant | Department of Health and Human Services · Phase II · Targeting glioblastoma stem-like cells with custom-designed viral vectors | $999,999 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2769 | DIAVACS, INC. | — | $850K |
| 2770 | OCEANYX PHARMACEUTICALS, INC. | — | — |
| 2771 | Niche Biopharmaceuticals LLC | — | $525K |
| 2772 | LACERTA THERAPEUTICS, INC. | — | $500K |
| 2773 | StaphOff Biotech, Inc. | — | $25K |
| 2774 | Arsenal Biosciences | — | $579M |
| 2775 | Invivyd, Inc. | — | $489M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Barry ByrneDirector · Promoter
- Nicholas MuzyczkaDirector
- Joseph ReddyDirector · Executive Officer · Promoter
- James RuscheDirector
- Kenneth WarringtonExecutive Officer · Promoter
- Sergei ZolotukhinDirector · Promoter
Patents
- Compositions And Methods For Treatment Of Friedreich's Ataxiaapplication
- Compositions And Methods For Treatment Of Friedreich's Ataxiaapplication
- Compositions And Methods For Treatment Of Friedreich's Ataxiaapplication
- Compositions And Methods For Treatment Of Friedreich's Ataxiaapplication
- Materials And Methods For Treatment Of Friedreich Ataxiaapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.